• 1. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Acrylic acids and derivatives

Recent Advances in the Application of (Z)-Isopropyl 3-iodoacrylate (CAS: 1333154-26-9) in Chemical Biology and Pharmaceutical Research

(Z)-Isopropyl 3-iodoacrylate (CAS: 1333154-26-9) has emerged as a versatile building block in synthetic organic chemistry and pharmaceutical research. This α,β-unsaturated ester with an iodine substituent at the β-position exhibits unique reactivity patterns that make it particularly valuable for the construction of complex molecular architectures. Recent studies have highlighted its applications in cross-coupling reactions, cycloadditions, and as a precursor for bioactive molecules.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of (Z)-Isopropyl 3-iodoacrylate in the synthesis of novel kinase inhibitors. The researchers utilized the compound's iodine moiety for efficient palladium-catalyzed cross-coupling reactions with various heterocyclic boronic acids, yielding a library of potential anticancer agents. The study reported several derivatives showing promising activity against EGFR and VEGFR kinases with IC50 values in the low nanomolar range.

In the field of antimicrobial drug development, a recent publication in Bioorganic & Medicinal Chemistry Letters (2024) described the use of (Z)-Isopropyl 3-iodoacrylate as a key intermediate in the synthesis of novel quinolone-3-carboxylic acid derivatives. The electron-deficient double bond facilitated [2+2] cycloaddition reactions with various imines, generating β-lactam structures with enhanced antibacterial activity against drug-resistant strains of Staphylococcus aureus.

The compound's stereochemistry has also been exploited in asymmetric synthesis. A 2024 Nature Catalysis paper reported an enantioselective conjugate addition of organozinc reagents to (Z)-Isopropyl 3-iodoacrylate catalyzed by a novel chiral N-heterocyclic carbene-copper complex. This methodology provided access to chiral β-iodo esters with excellent enantioselectivities (up to 98% ee), which were subsequently transformed into prostaglandin analogs with potential anti-inflammatory properties.

From a structural perspective, computational studies published in the Journal of Physical Chemistry A (2023) have provided insights into the conformational preferences and electronic properties of (Z)-Isopropyl 3-iodoacrylate. Density functional theory (DFT) calculations revealed that the Z-configuration is stabilized by n→π* interactions between the ester oxygen lone pairs and the π* orbital of the C=C bond, while the iodine atom participates in weak halogen bonding with the ester carbonyl oxygen.

Recent advances in continuous flow chemistry have also impacted the production and utilization of (Z)-Isopropyl 3-iodoacrylate. A 2024 Chemical Engineering Journal publication described a safe and scalable continuous process for its synthesis from propiolic acid derivatives, addressing previous challenges associated with handling the highly reactive intermediate in batch processes. The developed method achieved 85% yield with excellent purity (>99%) at a production rate of 500 g/h.

In conclusion, (Z)-Isopropyl 3-iodoacrylate (CAS: 1333154-26-9) continues to demonstrate significant value in pharmaceutical research and chemical biology. Its unique combination of reactivity, stereochemistry, and functional group compatibility makes it a powerful tool for medicinal chemists. Future research directions may explore its applications in PROTAC development, bioconjugation chemistry, and as a precursor for radioiodinated imaging agents.

• 103-11-7(2-Ethylhexyl acrylate)
• 105-76-0(Dibutyl maleate)
• 101-43-9(Cyclohexyl 2-Methylprop-2-enoate)
• 105-75-9(Dibutyl fumarate)
• 97-90-5(Ethylene dimethacrylate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)